WPW
ARKG icon

Waldron Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Waldron Private Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,776
Closed -$231K – 402
2021
Q4 		$231K Sell
3,776
-35
-0.9% -$2.42K 0.01% 344
2021
Q3 		$284K Buy
3,811
+200
+6% +$16.8K 0.02% 287
2021
Q2 		$334K Buy
3,611
+175
+5% +$14.9K 0.02% 257
2021
Q1 		$304K Buy
+3,436
New +$341K 0.02% 241

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Waldron Private Wealth's ARKG Position: Q1 2022 in Review

Waldron Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 3,776 shares — an estimated $231K sold.

Waldron Private Wealth first reported a position in ARKG in Q1 2021 and held it in 4 quarters. The position peaked at $334K in Q2 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Waldron Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Waldron Private Wealth sold 3,776 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $231K.
  • Waldron Private Wealth first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 4 quarters.
  • Waldron Private Wealth's ARK Genomic Revolution ETF position peaked at $334K in Q2 2021.
  • 387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Waldron Private Wealth's 13F filing for Q1 2022, filed 4 May 2022.